PDGF-Receptor Tyrosine Kinase Blocker AG1295 Selectively Attenuates Smooth Muscle Cell Growth In Vitro and Reduces Neointimal Formation After Balloon Angioplasty in Swine
Open Access
- 19 May 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 97 (19) , 1960-1969
- https://doi.org/10.1161/01.cir.97.19.1960
Abstract
Background—Signaling through protein tyrosine kinases (PTKs) is a major contributor to the transmission of mitogenic stimuli to the interior of the cell and nucleus. The present study was designed ...Keywords
This publication has 24 references indexed in Scilit:
- Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with InhibitorsScience, 1997
- Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury.Proceedings of the National Academy of Sciences, 1996
- Selective gene therapy for proliferative disorders: Sense and antisenseNature Medicine, 1996
- Targeting signal transduction for disease therapyCurrent Opinion in Cell Biology, 1996
- Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1 beta in pigs in vivo.Journal of Clinical Investigation, 1995
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995
- Signal-Transduction Therapy. A Novel Approach to Disease ManagementEuropean Journal of Biochemistry, 1994
- The pathway to signal achievementNature, 1993
- Inhibition of platelet-derived growth factor-induced mitogenesis and tyrosine kinase activity in cultured bone marrow fibroblasts by tyrphostinsExperimental Cell Research, 1992
- Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cellsAmerican Journal of Physiology-Cell Physiology, 1991